doi: 10.1016/j.jaip.2025.05.050.
Epub 2025 Jun 4.
Long-term effectiveness and safety of dupilumab in severe asthma: A 5-year real-world multicenter study
Astrid Chauvin
1
, Drifa Belhadi
2
, Clairelyne Dupin
1
, Laurent Guilleminault
3
, Amel Boudjemaa
4
, Nouha Ghourabi
2
, Anne-Sophie Gamez
5
, Patrick Berger
6
, Naji Khayat
7
, Philippe Bonniaud
8
, Christophe Leroyer
9
, Guillaume Mahay
10
, Stéphanie Fry
11
, Pierre-Olivier Girodet
6
, Geneviève Le Bourdellès
12
, Alain Proust
13
, Lise Rosencher
14
, Gilles Garcia
15
, Arnaud Bourdin
16
, Cécile Chenivesse
17
, Alain Didier
3
, Camille Couffignal
2
, Camille Taillé
18
Affiliations
Affiliations
- 1 Pneumology Department, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris; UMR 1149, Université Paris Cité, Paris, France.
- 2 Department of Epidemiology, Biostatistics, and Clinical Research Clinical Research Unit, Hôpital Bichat, Paris, France; Clinical Investigation Center CIC-EC 1425, Inserm, Université Paris Cité, Paris, France.
- 3 Respiratory Tract Division, Hôpital Larrey, CHU de Toulouse, F-31059, Toulouse, France; Pathophysiology Center Toulouse Purpan, INSERM U1043, CNRS UMR 5282, Université Toulouse III, Toulouse, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 4 Pneumology Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
- 5 Pneumology and Addictology Department, Hôpital Arnaud de Villeneuve, CHU Montpellier, Montpellier, France.
- 6 Pneumology Department, Inserm CIC1401, Bordeaux University Hospital, Bordeaux, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 7 INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 8 Pneumology and Respiratory Intensive Care Department, Dijon-Bourgogne University Hospital, Dijon, France; Faculty of Medicine and Pharmacy, University of Bourgogne-Franche Comté, Dijon, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 9 Department of Internal Medicine and Pneumology, Hôpital La Cavale Blanche, Brest, France; EA3878, Thrombosis Study Group of Western Brittany (GETBO), European University of Bretagne, Brest, France.
- 10 Pneumology, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France.
- 11 CHU Lille, Pneumology and Immunoallergology Department, Univ Lille, Institut Pasteur Lille, Lille, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 12 Pneumology Department, Hôpital Foch, Suresnes, France.
- 13 Pneumology Department, CH de Nîmes, Nîmes, France.
- 14 Department of Pneumology and Respiratory Intensive Care, Functional Thoracic Oncology Unit, Hôpital Tenon, AP-HP, Paris, France.
- 15 Pneumology Department, Antony hospital, Antony, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 16 Pathophysiology Center Toulouse Purpan, INSERM U1043, CNRS UMR 5282, Université Toulouse III, Toulouse, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 17 Department of Internal Medicine and Pneumology, Hôpital La Cavale Blanche, Brest, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 18 Pneumology Department, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris; UMR 1149, Université Paris Cité, Paris, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France. Electronic address: camille.taille@aphp.fr.
- PMID: 40480546
- DOI: 10.1016/j.jaip.2025.05.050
Item in Clipboard
Long-term effectiveness and safety of dupilumab in severe asthma: A 5-year real-world multicenter study
Astrid Chauvin et al.
J Allergy Clin Immunol Pract.
2025 Sep.
Display options
Format
doi: 10.1016/j.jaip.2025.05.050.
Epub 2025 Jun 4.
Authors
Astrid Chauvin
1
, Drifa Belhadi
2
, Clairelyne Dupin
1
, Laurent Guilleminault
3
, Amel Boudjemaa
4
, Nouha Ghourabi
2
, Anne-Sophie Gamez
5
, Patrick Berger
6
, Naji Khayat
7
, Philippe Bonniaud
8
, Christophe Leroyer
9
, Guillaume Mahay
10
, Stéphanie Fry
11
, Pierre-Olivier Girodet
6
, Geneviève Le Bourdellès
12
, Alain Proust
13
, Lise Rosencher
14
, Gilles Garcia
15
, Arnaud Bourdin
16
, Cécile Chenivesse
17
, Alain Didier
3
, Camille Couffignal
2
, Camille Taillé
18
Affiliations
- 1 Pneumology Department, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris; UMR 1149, Université Paris Cité, Paris, France.
- 2 Department of Epidemiology, Biostatistics, and Clinical Research Clinical Research Unit, Hôpital Bichat, Paris, France; Clinical Investigation Center CIC-EC 1425, Inserm, Université Paris Cité, Paris, France.
- 3 Respiratory Tract Division, Hôpital Larrey, CHU de Toulouse, F-31059, Toulouse, France; Pathophysiology Center Toulouse Purpan, INSERM U1043, CNRS UMR 5282, Université Toulouse III, Toulouse, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 4 Pneumology Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
- 5 Pneumology and Addictology Department, Hôpital Arnaud de Villeneuve, CHU Montpellier, Montpellier, France.
- 6 Pneumology Department, Inserm CIC1401, Bordeaux University Hospital, Bordeaux, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 7 INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 8 Pneumology and Respiratory Intensive Care Department, Dijon-Bourgogne University Hospital, Dijon, France; Faculty of Medicine and Pharmacy, University of Bourgogne-Franche Comté, Dijon, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 9 Department of Internal Medicine and Pneumology, Hôpital La Cavale Blanche, Brest, France; EA3878, Thrombosis Study Group of Western Brittany (GETBO), European University of Bretagne, Brest, France.
- 10 Pneumology, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France.
- 11 CHU Lille, Pneumology and Immunoallergology Department, Univ Lille, Institut Pasteur Lille, Lille, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 12 Pneumology Department, Hôpital Foch, Suresnes, France.
- 13 Pneumology Department, CH de Nîmes, Nîmes, France.
- 14 Department of Pneumology and Respiratory Intensive Care, Functional Thoracic Oncology Unit, Hôpital Tenon, AP-HP, Paris, France.
- 15 Pneumology Department, Antony hospital, Antony, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 16 Pathophysiology Center Toulouse Purpan, INSERM U1043, CNRS UMR 5282, Université Toulouse III, Toulouse, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 17 Department of Internal Medicine and Pneumology, Hôpital La Cavale Blanche, Brest, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France.
- 18 Pneumology Department, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris; UMR 1149, Université Paris Cité, Paris, France; INSERM, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation, Toulouse, France. Electronic address: camille.taille@aphp.fr.
- PMID: 40480546
- DOI: 10.1016/j.jaip.2025.05.050
Item in Clipboard
Display options
Format
No abstract available